-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Epilepsy is a neurological disease that affects more than 3 million Americans
.
The prognosis has proven to be driven by a variety of factors, including challenges in daily activities due to the risk of epilepsy, such as going to school, maintaining social relationships, employment, transportation, and independent living
Epilepsy is a neurological disease that affects more than 3 million Americans
The role of comorbidities in patients with epilepsy is still a vital area of epilepsy research
In addition to determining the overall prevalence of various disease combinations, it is also important to determine the racial and ethnic differences that accompany these conditions
Using five years of Medicaid claims data, the researchers identified adults with epilepsy and used all available claims and diagnoses to determine the set of clinical classification codes that each person diagnosed during the study
.
Using association rule mining, the top combinations of diseases are determined, and these combinations are stratified according to race/ethnicity to determine potential differences in prevalence
Using five years of Medicaid claims data, the researchers identified adults with epilepsy and used all available claims and diagnoses to determine the set of clinical classification codes for each person diagnosed during the study
- Among 81,963 patients, the most common diseases were anxiety and mood disorders (46.
This study showed a high incidence of mental and physical illnesses, and identified the racial and ethnic differences that affect patients with epilepsy
Literature source: https://n.
neurology.
org/content/early/2021/10/27/WNL.
0000000000012975.
long Literature source: https://n.
neurology.
org/content/early/2021/10/27 /WNL.
0000000000012975.
long https://n.
neurology.
org/content/early/2021/10/27/WNL.
0000000000012975.
long Leave a message here
